2024-09-15 - Analysis Report
## CVS Stock Analysis

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and healthcare services.

**Performance Analysis:**

**1. Performance Comparison:**

* **CVS's cumulative return:** -20.7%
* **S&P 500 (VOO) cumulative return:** 87.74%
* **Performance Difference:** -108.44%
* **Relative Performance:** 1.94 (The current performance is at the 1.94 percentile of the historical performance range). 

This shows that CVS has significantly underperformed compared to the S&P 500 over the period considered.

**2. Recent Price Movements:**

* **Closing Price:** $57.53
* **5-Day Moving Average:** $56.96
* **20-Day Moving Average:** $57.78
* **60-Day Moving Average:** $58.52

The stock price is currently below its 20-day and 60-day moving averages, indicating a potential downward trend. 

**3. Technical Indicators:**

* **RSI:** 49.02 (Neutral: Neither overbought nor oversold)
* **PPO:** -0.09 (Negative: Short-term weakness)
* **Delta_Previous_Relative_Divergence:** -2.66 (Negative: Short-term downtrend)
* **Expected Return:** 12.38% (Potential 5-year expected return on current investment)

The RSI suggests a neutral market sentiment, while the PPO and Delta_Previous_Relative_Divergence indicate potential short-term weakness. The expected return is moderately positive. 

**4. Recent Earnings & Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report (2024-08-07) showed a beat of 1.83 vs. 1.73 expected EPS. However, prior quarters showed mixed results, with both beats and misses. 

**5. Summary:**

CVS has significantly underperformed the S&P 500 in recent times, with a negative cumulative return. While its current price is below key moving averages, indicating a potential downward trend, the RSI suggests a neutral market sentiment.  However, the negative PPO and Delta_Previous_Relative_Divergence signals short-term weakness. The company's latest earnings beat expectations, but past performance has been mixed.  The expected return is moderately positive, suggesting a potential for future growth. 

**Overall:** The stock's performance has been weak compared to the market. The current price action signals potential downward pressure. However, the neutral RSI and positive expected return provide a glimmer of hope for long-term investors.  Further analysis and monitoring of the company's future earnings and market trends are recommended to assess the stock's potential. 
